Table 1.
Topic | Total priority score |
---|---|
PET/CT and lung cancer staging | 28 |
PET/CT and lung cancer surveillance | 23 |
PET/CT and head and neck cancer staging | 14 |
PET/CT and lymphoma surveillance | 23 |
PET/CT and thyroid cancer surveillance | 14 |
CEA and colorectal cancer surveillance | 25 |
CEA: Carcinoembryonic antigen; CT: Computed tomography.